This fact sheet summarizes the major statutory requirements and policies pertaining to U.S. global family planning/reproductive health (FP/RH) efforts over time and identifies those currently in effect, including the Mexico City Policy and the Kemp-Kasten Amendment.

An overview of the Mexico City Policy, which requires foreign NGOs to certify that they will not “perform or actively promote abortion as a method of family planning” using funds from any source (including non-U.S. funds) as a condition for receiving most U.S. government global health assistance.

This issue brief explains the legal and factual issues in dispute and the reviews the potential implications of different rulings in the case of June Medical Services v. Russo, which could have significant implications for women’s access to abortion and could eliminate the right of abortion providers to bring legal challenges to state and federal laws and policies.

This data note presents an interactive map that tracks which states have made declarations defining abortions as non-essential or elective health procedures and effectively blocking the provision of abortion services during the outbreak.

Several reproductive health care services have been considered “elective” and postponed during the pandemic. While much of the care deemed “non-essential” isn’t life-threatening, delaying care for too long can result in negative health outcomes.

This brief analyzes how states, health systems and providers have been faced with deciding what health care is “essential” verses “elective” during the COVID-19 crisis, and what the possible consequences are to delays in “non-essential” reproductive health care.

A new Coronavirus Policy Watch post from KFF explores how state responses to limit abortion access during the COVID-19 pandemic has drawn renewed attention to the provision of medication abortion using telemedicine approaches.  Medication abortion via telemedicine is a method that can be used to safely provide women with access…

This factsheet provides an overview of medication abortion, with a focus on federal and state regulations pertaining to its provision and coverage, and the role of the drug in self-managed abortions.

New analysis of KFF’s 2019 Employer Benefits Survey finds that 10% of workers covered by employer-sponsored health insurance are employed at a firm that has asked their insurer or third party administrator to exclude abortion coverage from their health plan. Employer-sponsored coverage is the primary source of health benefits in…

This issue brief presents data from the 2019 KFF Employer Health Benefits Survey on the share of covered workers who are employed by firms that have asked their insurer or third party administrator to exclude coverage for abortion from their health plan.